Most Cannabis Stocks Went Up in April – Are We Past the Bottom

Despite the volatility in the cannabis sector this past month its components did extremely well in April advancing by 10.8% with the Non-Penny Pot Stock Index (NPSI) slightly outperforming the overall sector with a 11.3% return.

By Lorimer Wilson, editor of munKNEE.com

The NPSI tracks the performance of the 35 cannabis stocks that trade for a minimum of US$1/share (representing 12% of the universe of 298 companies). Below are the details of the returns of each constituent within each of the 9 categories that represent their primary area of focus in the cannabis industry.

The performance of the NPSI constituents are presented below within each of the 9 categories in alphabetical order to allow for performance comparisons within similar areas of focus:

1. Cultivation & Retail Category:

   • category consists of companies that grow and sell cannabis flower and related products.
   • The constituents within this category performed as follows:
     1. Acreage Holdings Inc. (ACRGF)  -7.3%
     2. Alcanna Inc. (LQSIF) +10.0%
     3. Aphria Inc. (APHA) +17.3%
     4. Canopy Growth Corporation (CGC) +11.0%
     5. Columbia Care Inc. (CCHWF) +0.6%
     6. Cronos Group Inc. (CRON) +4.8%
     7. Curaleaf Holdings Inc. (CURLF) +19.8%
     8. FSD Pharma Inc. (HUGE) -14.0%
     9. Green Thumb Industries Inc. (GTBIF) +23.5% 
     10. MediPharm Labs Corp. (MEDIF) +25.9%
     11. Organigram Holdings Inc. (OGI) -21.0%
     12. Planet 13 Holdings Inc. (PLNHF) +15.8%
     13. Rubicon Organics Inc. (ROMJF) +47.3%
     14. TerrAscend Corp. (TRSSF) +19.9%
     15. Tilray Inc. (TLRY) +17.0%
     16. Trulieve Cannabis Corp. (TCNNF) +13.7%
     17. Valens GroWorks Corp. (VLNCF) -5.7% 
   • The average price change was +10.9%

2. Biotechnology Category:

   • category consists of pharmaceutical companies focused on R&D of new drugs and products utilizing cannabinoids.
   • The constituents within this category performed as follows:
     1. Abacus Health Products Inc. (ABAHF) +21.1%
     2. Avicanna Inc. (AVCNF) +91.0%
     3. Cara Therapeutics Inc. (CARA) +12.2%
     4. Corbus Pharmaceuticals Holdings Inc. (CRBP) +23.7%
     5. GW Pharmaceuticals Plc (GWPH) +14.4%
     6. Zynerba Pharmaceuticals Inc. (ZYNE) +1.0%
   • The average price change was +13.0%

3. Marijuana-Infused Products Category:

   • category consists of companies focused on developing and selling marijuana-infused products and companies focused on the extraction of cannabis compounds and their infusion into consumer products.
   • The constituents within this category performed as follows:
     1. Cresco Labs Inc. (CRLBF) +32.9%
     2. Neptune Wellness Solutions Inc. (NEPT) +78.6%
     3. New Age Beverages Corporation (NBEV) +1.4%
   • The average price change was +34.7%

…to continue reading the full post of this abridged article, please visit “Most Pot Stocks Went UP in April – Is the Bottom In?”

//

munKNEE.com is a new affiliate of eResearch.com. To learn more about munKNEE.com, please visit their website and sign-up for their weekly newsletter.